These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 25760387)

  • 1. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
    Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
    RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.
    Zhao Z; Ma X; Shelton SD; Sung DC; Li M; Hernandez D; Zhang M; Losiewicz MD; Chen Y; Pertsemlidis A; Yu X; Liu Y; Du L
    Oncotarget; 2016 Nov; 7(48):79372-79387. PubMed ID: 27764804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
    Koo KH; Kwon H
    Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
    Noonan EJ; Place RF; Basak S; Pookot D; Li LC
    Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.
    Li X; Li H; Zhang R; Liu J; Liu J
    Cell Physiol Biochem; 2015; 35(5):2033-42. PubMed ID: 25871967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.
    Chen H; Lin YW; Mao YQ; Wu J; Liu YF; Zheng XY; Xie LP
    Cancer Lett; 2012 Jul; 320(1):40-7. PubMed ID: 22266187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
    Afanasyeva EA; Mestdagh P; Kumps C; Vandesompele J; Ehemann V; Theissen J; Fischer M; Zapatka M; Brors B; Savelyeva L; Sagulenko V; Speleman F; Schwab M; Westermann F
    Cell Death Differ; 2011 Jun; 18(6):974-84. PubMed ID: 21233845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells.
    Ren XS; Yin MH; Zhang X; Wang Z; Feng SP; Wang GX; Luo YJ; Liang PZ; Yang XQ; He JX; Zhang BL
    Cancer Lett; 2014 Mar; 344(2):195-203. PubMed ID: 24211326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression.
    Li F; Liang J; Bai L
    Biomed Pharmacother; 2018 Jul; 103():782-789. PubMed ID: 29684857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [miR-449b and miR-34c on inducing down-regulation of cell cycle-related proteins and cycle arrests in SKOV3-ipl cell, an ovarian cancer cell line].
    Ma Lp; Li N; He Xj; Zhang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):129-33. PubMed ID: 21321636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
    Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
    Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells.
    Mao A; Liu Y; Wang Y; Zhao Q; Zhou X; Sun C; Di C; Si J; Gan L; Zhang H
    Tumour Biol; 2016 Apr; 37(4):4831-40. PubMed ID: 26520443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.
    Kouhkan F; Mobarra N; Soufi-Zomorrod M; Keramati F; Hosseini Rad SM; Fathi-Roudsari M; Tavakoli R; Hajarizadeh A; Ziaei S; Lahmi R; Hanif H; Soleimani M
    J Med Genet; 2016 Jan; 53(1):24-33. PubMed ID: 26510428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
    Lizé M; Pilarski S; Dobbelstein M
    Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.
    Chen X; Pan M; Han L; Lu H; Hao X; Dong Q
    FEBS Lett; 2013 Nov; 587(22):3729-37. PubMed ID: 24140344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes.
    Chowdhari S; Saini N
    J Cell Physiol; 2014 Nov; 229(11):1630-8. PubMed ID: 24610393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.